Sort
21,453 grants matching “tuberculosis”
Stigma and Tuberculosis in Haitian Populations
$165,448University Of South Florida · R01 · FY2005 · TW
Inflammatory determinants of disease severity and treatment outcome in TB patients
$165,437Robert John Wilkinson · University Of Cape Town · U01 · FY2016 · AI
A link between sleep-wake disturbances and enlarged perivascular spaces in youth with traumatic brain injury
$165,390Juan Andres Piantino · Oregon Health & Science University · K23 · FY2022 · HL
Rapid screening for modes-of-action of M. tuberculosis inhibitors by high-throughput metabolic fingerprinting
$165,215Michael Berney · Albert Einstein College Of Medicine · R21 · FY2018 · AI
An Inhaled Clofazimine Formulation for the Treatment of Tuberculosis
$165,180Jared Franklin Mike · Lynntech, Inc. · R43 · FY2018 · AI
Directly observed antiretroviral therapy in drug abusers
$165,151Gregory M Lucas · Johns Hopkins University · K23 · FY2006 · DA
Heme-Dependent Chemistry in Tyrosine Oxidation
$165,108Aimin Liu · University Of Texas San Antonio · R01 · FY2020 · GM
Central Africa International Epidemiology databases to Evaluate AIDS
$165,100Marcel Yotebieng · Albert Einstein College Of Medicine · U01 · FY2025 · AI
Short term heart, lung, blood research opportunities
$165,078Monica Montano · Case Western Reserve University · R25 · FY2019 · HL
Short term heart, lung, blood research opportunities
$165,078Monica Montano · Case Western Reserve University · R25 · FY2015 · HL
Short term heart, lung, blood research opportunities
$165,078Monica Montano · Case Western Reserve University · R25 · FY2016 · HL
Short term heart, lung, blood research opportunities
$165,078Monica Montano · Case Western Reserve University · R25 · FY2017 · HL
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine
$164,973Anthony T Podany · University Of Nebraska Medical Center · K23 · FY2018 · AI
URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence
$164,963Judith Alissa Hahn · University Of California, San Francisco · U01 · FY2021 · AA
Flexible InteRvention Strategy for TB prevention (FIRST) study
$164,884Yael R Hirsch-Moverman · Columbia University Health Sciences · R21 · FY2021 · AI
Large-Scale Conformational Changes in Regulation of Transcription Initiation
$164,855M. Thomas Record · University Of Wisconsin-Madison · R01 · FY2011 · GM
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine
$164,763Anthony T Podany · University Of Nebraska Medical Center · K23 · FY2019 · AI
A link between sleep-wake disturbances and enlarged perivascular spaces in youth with traumatic brain injury
$164,682Juan Andres Piantino · Oregon Health & Science University · K23 · FY2024 · HL
Combination Antibotics as a Treatment for Chlamydia-Induced Reactive Arthritis
$164,518John Dillon Carter · University Of South Florida · R21 · FY2007 · AR
Mentoring in HIV and Tuberculosis Research
$164,477Timothy R Sterling · Vanderbilt University · K24 · FY2006 · AI
Enhanced STI management to reduce genital inflammation and HIV risk
$164,432Nigel Joel Garrett · Centre/Aids Programme/Res/South Africa · R21 · FY2016 · AI
International Core
$164,428Harvey Michael Friedman · University Of Pennsylvania · P30 · FY2018 · AI
Low Cost Mobile Platform for Pulmonary Disease Screening
$164,421Richard Fletcher · Massachusetts Institute Of Technology · R21 · FY2017 · TW
Genome Assemblies, Analyses, and Comparisons
$164,370Leonardo Marino-Ramirez · National Library Of Medicine · ZIA · FY2013 · LM
Fluoroquinolone resistance in patients with multidrug-resistant tuberculosis
$164,356Yuri F. Van Der Heijden · Vanderbilt University Medical Center · K08 · FY2016 · AI